38718 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 

computational workflows to facilitate 

chemical safety assessment, by 

NICEATM. 

Availability of Report: The report is 

available at http://ntp.niehs.nih.gov/ 

iccvamreport/2017/index.html. Links to 

this report and all past ICCVAM annual 

and biennial reports are available at 

http://ntp.niehs.nih.gov/go/iccvam-bien. 

Background Information on ICCVAM 

and NICEATM: ICCVAM is an 

interagency committee composed of 

representatives from 16 federal 

regulatory and research agencies that 

require, use, generate, or disseminate 

toxicological and safety testing 

information. ICCVAM conducts 

technical evaluations of new, revised, 

and alternative safety testing methods 

and integrated testing strategies with 

regulatory applicability. ICCVAM also 

promotes the scientific validation and 

regulatory acceptance of testing 

methods that more accurately assess the 

safety and hazards of chemicals and 

products and replace, reduce, or refine 

(enhance animal well-being and lessen 

or avoid pain and distress) animal use. 

The ICCVAM Authorization Act of 

2000 (42 U.S.C. 285l–3) establishes 

ICCVAM as a permanent interagency 

committee of NIEHS and provides the 

authority for ICCVAM involvement in 

activities relevant to the development of 

alternative test methods. Additional 

information about ICCVAM can be 

found at http://ntp.niehs.nih.gov/go/ 

iccvam. 

NICEATM administers ICCVAM, 

provides scientific and operational 

support for ICCVAM-related activities, 

and conducts and publishes analyses 

and evaluations of data from new, 

revised, and alternative testing 

approaches. NICEATM and ICCVAM 

work collaboratively to evaluate new 

and improved testing approaches 

applicable to the needs of U.S. federal 

agencies. NICEATM and ICCVAM 

welcome the public nomination of new, 

revised, and alternative testing 

approaches for validation studies and 

technical evaluations. Additional 

information about NICEATM can be 

found at http://ntp.niehs.nih.gov/go/ 

niceatm. 

Dated: July 24, 2018. 

Brian R. Berridge, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2018–16837 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases Notice 

of Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of 

meetings of the National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council. 

Date: September 7, 2018. 

Open: 8:30 a.m. to 12:00 p.m. 

Agenda: To present the Director’s Report 

and other scientific presentations. 

Place: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room 10, 31 Center Drive, Bethesda, MD 

20892. 

Closed: 1:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room 10, 31 Center Drive, Bethesda, MD 

20892. 

Contact Person: Karl F. Malik, Ph.D., 

Acting Director, Division of Extramural 

Activities, National Institutes of Diabetes and 

Digestive and Kidney Diseases, 6707 

Democracy Blvd., Room 7329, MSC 5452, 

Bethesda, MD 20892, (301) 594–4757, 

malikk@niddk.nih.gov. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council; Kidney, Urologic and Hematologic 

Diseases Subcommittee. 

Date: September 7, 2018. 

Open: 1:00 p.m. to 2:45 p.m. 

Agenda: To review the Division’s scientific 

and planning activities. 

Place: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room 7, 31 Center Drive, Bethesda, MD 

20892. 

Closed: 2:45 p.m. to 3:15 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room 7, 31 Center Drive, Bethesda, MD 

20892. 

Contact Person: Karl F. Malik, Ph.D., 

Acting Director, Division Of Extramural 

Activities, National Institutes of Diabetes and 

Digestive and Kidney Diseases, 6707 

Democracy Blvd., Room 7329, MSC 5452, 

Bethesda, MD 20892, (301) 594–4757, 

malikk@niddk.nih.gov. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council; Diabetes, Endocrinology, and 

Metabolic Diseases Subcommittee. 

Date: September 7, 2018. 

Open: 1:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room 10, 31 Center Drive, Bethesda, MD 

20892. 

Closed: 2:00 p.m. to 3:15 p.m. 

Agenda: To review the Division’s scientific 

and planning activities. 

Place: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room 10, 31 Center Drive, Bethesda, MD 

20892. 

Contact Person: Karl F. Malik, Ph.D., 

Acting Director, Division Of Extramural 

Activities, National Institutes of Diabetes and 

Digestive and Kidney Diseases, 6707 

Democracy Blvd., Room 7329, MSC 5452, 

Bethesda, MD 20892, (301) 594–4757, 

malikk@niddk.nih.gov. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council; Digestive Diseases and Nutrition 

Subcommittee. 

Date: September 7, 2018. 

Open: 1:00 p.m. to 2:00 p.m. 

Agenda: To review the Division’s scientific 

and planning activities. 

Place: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room 6, 31 Center Drive, Bethesda, MD 

20892. 

Closed: 2:15 p.m. to 3:15 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, C Wing, 6th Floor, Conference 

Room 6, 31 Center Drive, Bethesda, MD 

20892. 

Contact Person: Karl F. Malik, Ph.D., 

Acting Director, Division of Extramural 

Activities, National Institutes of Diabetes and 

Digestive and Kidney Diseases, 6707 

Democracy Blvd., Room 7329, MSC 5452, 

Bethesda, MD 20892, (301) 594–4757, 

malikk@niddk.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 38719 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www.niddk.nih.gov/fund/divisions/DEA/ 

Council/coundesc.htm., where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 1, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16790 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2018–0495] 

Merchant Mariner Medical Advisory 

Committee 

AGENCY: U.S. Coast Guard, Department 

of Homeland Security. 

ACTION: Notice of Federal Advisory 

Committee Meeting. 

SUMMARY: The Merchant Mariner 

Medical Advisory Committee and its 

Working Groups will meet to discuss 

matters relating to medical certification 

determinations for issuance of licenses, 

certificates of registry, and merchant 

mariners’ documents, medical standards 

and guidelines for the physical 

qualifications of operators of 

commercial vessels, medical examiner 

education, and medical research. The 

meetings will be open to the public. 

DATES: 

Meetings: The Merchant Mariner 

Medical Advisory Committee and its 

Working Groups are scheduled to meet 

on Thursday, September 13, 2018, and 

on Friday, September 14, 2018, from 

8:00 a.m. until 5:30 p.m. each day. 

These meetings may adjourn early if the 

Committee has completed its business. 

Comments and supporting 

documentation: To ensure your 

comments are received by Committee 

members before the meetings, submit 

your written comments no later than 

September 5, 2018. 

ADDRESSES: The meetings will be held at 

STAR Center, 2 West Dixie Highway, 

Dania Beach, FL 33004, https://

www.star-center.com/. 

Pre-registration Information: Preregistration is not required for access to 

this meeting by the public. All attendees 

will be required to provide a driver’s 

license or government-issued 

identification card in order to gain 

admittance to the building. 

For information on facilities or 

services for individuals with disabilities 

or to request special assistance at the 

meeting, contact the Alternate 

Designated Federal Officer as soon as 

possible using the contact information 

provided in the FOR FURTHER

INFORMATION CONTACT section of this 

notice. 

Instructions: You are free to submit 

comments at any time, including orally 

at the meetings, but if you want 

Committee members to review your 

comment before the meetings, please 

submit your comments no later than 

September 5, 2018. We are particularly 

interested in comments on the issues in 

the ‘‘Agenda’’ section below. You must 

include ‘‘Department of Homeland 

Security’’ and the docket number 

USCG–2018–0495. Written comments 

may also be submitted using the Federal 

eRulemaking Portal at http://

www.regulations.gov. If you encounter 

technical difficulties with comments 

submission, contact the individual 

listed in the FOR FURTHER INFORMATION

CONTACT section below. Comments 

received will be posted without 

alteration at http://www.regulations.gov, 

including any personal information 

provided. You may review the Privacy 

and Security Notice for the Federal 

Docket Management System at https://

www.regulations.gov/privacyNotice. 

Docket Search: For access to the 

docket, to read documents or comments 

related to this notice, go to http://

www.regulations.gov, type USCG–2018– 

0495 in the ‘‘Search’’ box, press Enter, 

and then click on the item you wish to 

view. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Davis Breyer, Alternate Designated 

Federal Officer of the Merchant Mariner 

Medical Advisory Committee, 2703 

Martin Luther King Jr. Ave. SE, Stop 

7509, Washington, DC 20593–7509, 

telephone 202–372–1445, fax 202–372– 

8382 or davis.j.breyer@uscg.mil. 

SUPPLEMENTARY INFORMATION: Notice of 

this meeting is pursuant with the 

Federal Advisory Committee Act, Title 

5 United States Code Appendix. 

The Merchant Mariner Medical 

Advisory Committee Meeting is 

authorized by U.S. Code, Title 46, 

section 7115. The Committee advises 

the Secretary of the Department of 

Homeland Security on matters related to 

(a) medical certification determinations 

for issuance of licenses, certificates of 

registry, and merchant mariners’ 

documents; (b) medical standards and 

guidelines for the physical 

qualifications of operators of 

commercial vessels; (c) medical 

examiner education; and (d) medical 

research. 

Agenda 

Day 1 

The agenda for the September 13, 

2018, meeting is as follows: 

(1) The full Committee will meet 

briefly to discuss the Working Groups’ 

business/task statements, which are 

listed under paragraph 2 and 3 (a)–(b) 

below. 

(2) General Discussion of Mariner 

Mental Health Issues with presentations 

by mariner service organizations and 

industry. 

(3) Working Groups will separately 

address the following task statements, 

which are available at https://

homeport.uscg.mil/missions/ports-andwaterways/safety-advisory-committees/ 

medmac. 

(a) Task statement 16–24 

Recommendations on Appropriate Diets 

and Wellness for Mariners While 

Onboard Merchant Vessels; and 

(b) Task statement 17–26, Input to 

Support Regulatory Reform of Coast 

Guard Regulations-Executive Orders 

13771 and 13783. 

(4) Public comment period. 

(5) Reports of Working Groups. At the 

end of the day, the Working Groups will 

report to the full Committee on what 

was accomplished in their meetings. 

The full Committee will not take action 

on these reports on this date. Any 

official action taken as a result of these 

Working Group meetings will be taken 

on day two of the meeting. 

(6) Adjournment of meeting. 

Day 2 

The agenda for the September 14, 

2018, meeting is as follows: 

(1) Introduction. 

(2) Designated Federal Officer 

announcements. 

(3) Remarks from U.S. Coast Guard 

Leadership. 

(4) Roll call of Committee members 

and determination of a quorum. 

(5) Reports from the following 

Working Groups: 

(a) Task statement 16–24, requesting 

recommendations on appropriate diets 


daltland on DSKBBV9HB2PROD with NOTICES